Apimeds and MindWave Announce Merger, Integrating Biotech Growth with AI-Driven Digital Treasury Yield Generation Backed by $100M PIPE

Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) announced a merger with MindWave Innovations Inc, uniting Apimeds’ late-stage, non-opioid pain-management biologic portfolio with MindWave’s AI-driven Bitcoin treasury, digital asset yield generation, and $NILA-powered ecosystem. The combined company integrates high-growth biotechnology and institutional digital-treasury capabilities, with the merger supported by a simultaneous PIPE of up to $100 … [Read more…]

Novocure Appoints Company President Frank Leonard as Chief Executive Officer

BAAR, Switzerland–(BUSINESS WIRE)–$NVCR–Novocure (NASDAQ: NVCR) today announced the appointment of Frank Leonard as Chief Executive Officer (CEO), effective immediately. Mr. Leonard previously served as President of Novocure and succeeds Ashley Cordova who has resigned from the company. “During his more than 15-year career at Novocure, Frank has led many of our global business operations developing … [Read more…]

GE HealthCare builds on a century of innovation to shape the future of radiology at RSNA 2025

The company will showcase a wave of transformative innovations designed to address the most pressing challenges in healthcare, spanning the care journey across smart devices and drugs throughout disease states enabled by cloud and AI solutions. GE HealthCare has invested more than $3B in R&D since 2022, delivering an innovation renaissance across disease states to … [Read more…]

GE HealthCare unveils next-generation SIGNA MRI technology, aiming to boost efficiency, enhance patient experience, and advance sustainability

SIGNA Bolt1, a new 3T MRI scanner, is designed with a next-gen gradient system engineered to support precision diagnostics, clinical efficiency, and advanced research capability. SIGNA Sprint with Freelium,2 a new sealed magnet MRI system, seeks to reimagine 1.5T MRI by combining a sustainable design with remarkable image quality, and operational autonomy to expand access … [Read more…]

The Urgency Still Remains for HIV: AHF UK Marks World AIDS Day

LONDON–(BUSINESS WIRE)–#AIDS–In honour of World AIDS Day 2025, AIDS Healthcare Foundation (AHF) UK will host two community events to emphasize that the work to end HIV/AIDS is not over. The first commemoration will take place on Monday, 1 December, at the Croydon BME Forum Wellness Centre in the Whitgift Shopping Centre (1st Floor, CR0 1LP), … [Read more…]

Not Just About Dating: How PositiveSingles Helps People with STDs Build Connection

LOS ANGELES–(BUSINESS WIRE)–In today’s digital dating world, conversations around sexual health are often avoided or treated as taboo. While some mainstream dating platforms have begun encouraging users to disclose their sexual health before meeting, many companies still hesitate to associate their brand with topics such as herpes and other STDs. However, PositiveSingles has chosen a … [Read more…]

Fifty Countries Strong: AHF ‘Keeping the Promise’ on World AIDS Day

M.O.U. cements Bangladesh as AIDS Healthcare Foundation’s newest country Global nonprofit cares for over 2.7 million people worldwide; adds Tennessee and Michigan to U.S. roster LOS ANGELES–(BUSINESS WIRE)–To mark World AIDS Day 2025, AIDS Healthcare Foundation (AHF) will hold major commemorative concerts and events in early December across Africa, Asia, Europe, and the Americas to … [Read more…]

CAR T-Cell Therapy for the Multiple Myeloma Market, 2025-2035: Extensive Data on Products, End Users, Regions and Companies – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “CAR T-Cell Therapy for Multiple Myeloma Market – A Global and Regional Analysis: Focus on Product, End User, and Region – Analysis and Forecast, 2025-2035” has been added to ResearchAndMarkets.com’s offering. The chimeric antigen receptor (CAR) T-cell therapy has emerged as a groundbreaking treatment modality, offering new hope for patients with relapsed or … [Read more…]

2 Day Virtual Biological Evaluation of Medical Devices Training Course: Ensure Compliance with the ISO 10993 Series of Standards for the Biological Evaluation of Medical Devices (Jan 21st-22nd, 2026) – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Biological Evaluation of Medical Devices Training Course (Jan 21st – Jan 22nd, 2026)” training has been added to ResearchAndMarkets.com’s offering. Ensure compliance with the ISO 10993 series of standards for the biological evaluation of medical devices, as it is well-established and expected by regulatory authorities worldwide. In the European Union, compliance with these … [Read more…]